Osteoporotic Vertebral Fracture Clinical Trial
Official title:
Prospective Randomized Study of Balloon Kyphoplasty and Vertebroplasty in Subacute (Older Than 6 Weeks) Osteoporotic Vertebral Fractures (STIC2)
This study aims to compare two treatments in subacute (more than 6 week duration)
non-traumatic (usually osteoporotic) vertebral fractures. The two treatments are the
following:
1. Vertebroplasty consisting in the percutaneous injection into the fractured vertebra of
polymethylmetacrylate cement (the cement used to fix prosthesis in joint replacement)
through a posterior route through the vertebral pedicles under radiological guidance.
2. Balloon Kyphoplasty which consists of placing through a percutaneous posterior approach
under radiological guidance, into the fractured vertebra a balloon which is inflated
with fluid and creates a cavity. This may restore part of the vertebral height loss due
to the fracture. In addition, after balloon deflation, polymethylmetacrylate cement is
injected with low pressure into the created cavity to fix fracture reduction. The study
will indicate if balloon kyphoplasty is able to restore vertebral height of the
fractured vertebra better than vertebroplasty.
Vertebral compression fractures can occur at any level in the vertebral column but the most
frequent ones occur at the thoracic (T8-T12) and lumbar spine (L1 and L4). Multiple
vertebrae are often concerned. Vertebral fractures are characterized by height reduction of
the involved vertebral bodies and very often also by kyphosis and laterally dorsal pain
laterally irradiating towards the two sides of the back. A spontaneous improvement of this
pain can occur spontaneously within 6 to 12 weeks, but a large number of patients develop a
chronic pain and associated morbidity, due to the side effects caused by the fractureThe
main cause (85%) of non-traumatic vertebral compression fractures is osteoporosis, in
particular in elderly patients. In osteoporotic vertebral fractures older than 6 weeks,
conservative management is purely symptomatic, with no effect on the compression fracture
itself. Two alternatives are available: Percutaneous Vertebroplasty and Percutaneous Balloon
Kyphoplasty
1. Percutaneous Vertebroplasty is a percutaneous treatment of vertebral fractures which is
used now for more than 25 years. It was first reported in aggressive vertebral
hemangiomas and vertebral malignancies and than in osteoporotic vertebral fractures.
More recently, vertebroplasty was used in traumatic vertebral fracture.Vertebroplasty
is performed under fluoroscopic guidance with the patient in prone position under
general or local anesthesia and conscious sedation. A trocar needle is inserted through
a posterior approach into the vertebral neural arch and pedicle, up to the fractured
vertebral body. Depending on cases a unilateral or bilateral approach is used. A
bilateral approach is used in the cases of traumatic fractures. Once the needle is well
positioned into the vertebral body as checked on apical and Lateral views, a
radio-opaque cement, in a viscous phase, is slowly injected into the vertebral body
under continuous fluoroscopic control. The injection is stopped in case of cement
leakage outside from the vertebral body. Polymethylmetacrylate is the most commonly
used cement. Its biologic compatibility is well established since used in orthopedic
surgery for many decades. Some operators are reluctant to use a non-resorbable cement
in young patients. However, to date, the ideal resorbable injectable cement to be
discovered. Vertebroplasty allows rapid fracture fixation and decrease in pain, thus
allowing the patient to resume walking and daily activities in the days following the
procedure. Vertebroplasty does not reduce significantly the kyphosis angle due to the
fracture unless nonunion is present in the fracture line.
2. Percutaneous Balloon Kyphoplasty is a variant of vertebroplasty which is performed
under general anaesthesia using the KyphX® System (Medtronic, Sunnyvale, California).
Balloon kyphoplasty aims at restore vertebral height of the fractured vertebra using an
inflatable balloon prior to inject surgical cement (PMMA) into the vertebral body and
fix the fracture. It is an expensive technique costing around 4,000 euros for up to 2
vertebrae in the same patient. The surgical technique for the procedure has been
described by Lieberman et al. A bilateral approach is chosen to insert working cannulas
into the posterior part of the vertebral body. Fluoroscopy is used to insert the tools
and control the procedure. With reaming tools, two working channels are created and the
balloons are inserted. The balloons are available in lengths of 10, 15 and 20 mm.The
two balloons(one on each side) should ideally be centered at middle height between the
superior and inferior endplates and in the anterior two-thirds of the vertebral body.
Balloon placement into the vertebral body is checked using radiopaque markers at the
two extremities of the balloon. Once inserted, the balloons are inflated using visual,
volume and pressure control to create a cavity. Inflation is stopped when one of the
following inflation endpoints is reached: pressure raised over 400 psi, balloon
contacts one of the cortical bone of the vertebra or reaching maximal balloon inflation
volume. The balloons are then deflated and removed. The mean balloon inflation volume
is 2 to 3ml. The Bone Filler Device, filled before with 1.5 ml of
polymethylmethacrylate (PMMA), is then advanced through the working cannula towards the
anterior part of the cavity and cement is slowly extruded by a stainless steel stylet,
acting as a plunger. When the amount of cement from the first Bone Filler Device is
delivered in the cavity, it is removed and another Bone Filler Device is advanced
through the working cannula. This step is repeated till a complete fill of the cavity
is obtained. The same procedure is repeated through the other working cannula at the
contra-lateral pedicle. Filling of the cavity with highly viscous PMMA is performed
under continuous fluoroscopic control.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01990365 -
The Influence of Vertebral Mobility on Low Back Pain in Patients With Acute Osteoporotic Vertebral Fractures
|
N/A | |
Completed |
NCT00749060 -
Comparison of Balloon Kyphoplasty, Vertebroplasty and Conservative Management in Acute Osteoporotic Vertebral Fractures
|
N/A | |
Recruiting |
NCT06172179 -
Construction and Validation of a Risk Prediction Model for Secondary Vertebral Fracture in Patients With Osteoporotic Vertebral Compression Fractures After Percutaneous Vertebroplasty
|